Denton John Russel 4
4 · Caris Life Sciences, Inc. · Filed Jun 23, 2025
Insider Transaction Report
Form 4
Denton John Russel
See Remarks
Transactions
- Disposition to Issuer
Common Stock
2025-03-03$18.60/sh−238,230$4,431,078→ 16,770 total - Award
Common Stock
2025-06-18+99,321→ 116,091 total - Purchase
Common Stock
2025-06-20$21.00/sh+7,500$157,500→ 123,591 total - Award
Stock Option
2025-03-03+255,000→ 255,000 totalExercise: $18.60Exp: 2035-03-03→ Common Stock (255,000 underlying)
Holdings
- 5,000(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Represents shares of Common Stock surrendered to the Issuer as repayment for an outstanding promissory note.
- [F2]These securities were previously reported on the Reporting Person's Form 3. All the securities reported in this Form 4 reflect a one-for-four reverse stock split effected as of June 1, 2025.
- [F3]Represents an award of restricted stock units which vest in accordance with the applicable grant agreement.
- [F4]The stock option vested 60% at grant and will vest 20% on September 1, 2025 and 20% on September 1, 2026. These securities were previously reported on the Reporting Person's Form 3.